Iovance Biotherapeutics Inc (IOVA)

Jan 21, 2025

(IOVA) Technical Pivots with Risk Controls - Stock Traders Daily

Jan 21, 2025

Jan 21, 2025

Iovance Biotherapeutics (NASDAQ:IOVA) Sets New 52-Week LowHere's Why - MarketBeat

Jan 21, 2025

Jan 21, 2025

Cervical Cancer Market Expected to Experience Major Growth - openPR

Jan 21, 2025

Jan 20, 2025

Billionaire Joseph Edelman’s Top 10 Long-Term Stock Picks - Insider Monkey

Jan 20, 2025

Jan 20, 2025

Is Iovance Biotherapeutics (IOVA) Among Billionaire Joseph Edelman’s Long-Term Stock Picks? - Yahoo Finance

Jan 20, 2025

Jan 19, 2025

1,746,877 Shares in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Purchased by Assenagon Asset Management S.A. - MarketBeat

Jan 19, 2025

Jan 17, 2025

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - GlobeNewswire

Jan 17, 2025

Jan 17, 2025

Iovance Biotherapeutics Awards 224,550 Stock Options to Expand Team with 41 New Hires - StockTitan

Jan 17, 2025

Jan 17, 2025

First Week of September 19th Options Trading For Iovance Biotherapeutics (IOVA) - Nasdaq

Jan 17, 2025

Jan 16, 2025

Iovance Biotherapeutics (NASDAQ:IOVA) Sets New 1-Year LowTime to Sell? - MarketBeat

Jan 16, 2025

Jan 13, 2025

Oversold Conditions For Iovance Biotherapeutics (IOVA) - Nasdaq

Jan 13, 2025

Jan 11, 2025

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) May Have Run Too Fast Too Soon With Recent 25% Price Plummet - Simply Wall St

Jan 11, 2025

Jan 11, 2025

How To Trade (IOVA) - Stock Traders Daily

Jan 11, 2025

Jan 10, 2025

Cancer Drug Maker Iovance Tumbles Toward Worst Week Since November, But Retail Feels Macro Selloff Overblown - MSN

Jan 10, 2025

Jan 10, 2025

Iovance Biotherapeutics (NASDAQ:IOVA) Stock Price Down 7.8%Here's Why - MarketBeat

Jan 10, 2025

Jan 10, 2025

Iovance Biotherapeutics Shares Are Falling Today: What's Going On? - Benzinga

Jan 10, 2025

Jan 09, 2025

Immunotoxins Market Trends and Regional Business Opportunities, 2024-2034: Diphtheria Toxin-Based Immunotoxins Lead Revenue, Pseudomonas Exotoxins Show Rapid Growth Potential - GlobeNewswire Inc.

Jan 09, 2025

Jan 03, 2025

Iovance Biotherapeutics (IOVA) Surges on Positive Analyst Outloo - GuruFocus.com

Jan 03, 2025

Jan 03, 2025

Why Iovance Biotherapeutics Stock Zoomed More Than 5% Higher Today - MSN

Jan 03, 2025

Jan 02, 2025

Stifel maintains Buy on Iovance Biotherapeutics stock, optimistic on Amtagvi By Investing.com - Investing.com Canada

Jan 02, 2025

Jan 02, 2025

Iovance Biotherapeutics (NASDAQ:IOVA) Shares Up 7.7%What's Next? - MarketBeat

Jan 02, 2025

Jan 02, 2025

Why Iovance Biotherapeutics Inc. (IOVA) Is Skyrocketing - MSN

Jan 02, 2025

Jan 02, 2025

Analysts Set Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Price Target at $23.00 - MarketBeat

Jan 02, 2025

Dec 31, 2024

Philly’s year in biopharma: a look back at 2024 - The Philadelphia Inquirer

Dec 31, 2024

Dec 26, 2024

The Immunotherapy Boom: What It Means for the Future of Cancer Treatment - Baystreet.ca

Dec 26, 2024

Dec 24, 2024

Principal Financial Group Inc. Has $37.87 Million Stake in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) - MarketBeat

Dec 24, 2024

Dec 23, 2024

Geode Capital Management LLC Cuts Position in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) - MarketBeat

Dec 23, 2024

Dec 21, 2024

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Shares Purchased by Barclays PLC - MarketBeat

Dec 21, 2024

Dec 21, 2024

Where are the Opportunities in (IOVA) - Stock Traders Daily

Dec 21, 2024

Dec 19, 2024

Insiders' US$48.3m Investments In Red Following Iovance Biotherapeutics' US$402m Dip In Market Value - Simply Wall St

Dec 19, 2024

Dec 18, 2024

Iovance Biotherapeutics is Now Oversold (IOVA) - Nasdaq

Dec 18, 2024

Dec 17, 2024

KEI Comments on NIH Exclusive License to Iovance for T-cell Vaccine for Cancer Treatment - Knowledge Ecology International

Dec 17, 2024

Dec 16, 2024

Iovance Biotherapeutics: Amtagvi Launch Growing, But Stock Isn't (NASDAQ:IOVA) - Seeking Alpha

Dec 16, 2024

Dec 16, 2024

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Sees Significant Increase in Short Interest - MarketBeat

Dec 16, 2024

Dec 15, 2024

State Street Corp Grows Holdings in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) - MarketBeat

Dec 15, 2024

Dec 13, 2024

Iovance Biotherapeutics' SWOT analysis: promising TIL therapy stock faces growth hurdles - Investing.com India

Dec 13, 2024

Dec 12, 2024

Interesting IOVA Call Options For January 2025 - Nasdaq

Dec 12, 2024

Dec 12, 2024

Prediction: This Stock Will Beat the Market in 2025 - Yahoo Finance

Dec 12, 2024

Dec 11, 2024

BNP Paribas Financial Markets Trims Stock Holdings in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) - MarketBeat

Dec 11, 2024

Dec 09, 2024

Iovance Biotherapeutics' SWOT analysis: stock shows promise amid challenges By Investing.com - Investing.com Nigeria

Dec 09, 2024

Dec 09, 2024

Iovance Biotherapeutics: Steady Progress (NASDAQ:IOVA) - Seeking Alpha

Dec 09, 2024

Dec 08, 2024

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Dec 08, 2024